Women with more severe vasomotor symptoms and night sweats may be at risk of having poorer bone health, according to a prospective observational study.
Women with more severe vasomotor symptoms (VMS) and night sweats may be at risk of having poorer bone health, according to a prospective observational study based on data from the Women’s Health Initiative (WHI).
More than 27,000 women aged 50 to 79 from two WHI cohorts were represented: 23,573 who had not used menopausal hormone therapy and 4,867 from the bone mineral density (BMD) cohort. Mean follow-up was 8.2 years (1993-2005). The researchers measured baseline VMS and incident adjudicated fractures, and BMD at baseline and the first, third, sixth, and ninth annual visits.
After adjusting for variables such as body mass index, race/ethnicity, smoking, education, and age at baseline, the hazard ratio for hip fracture among women with baseline moderate to severe VMS versus those with no VMS was 1.78 (95% confidence interval [CI] 1.20 – 2.65, P = .01), No association was found between vertebral fracture and VMS. Over the course of follow-up, severity of VMS was inversely associated with BMD (P = .004 for femoral neck, P = .045 for lumbar spine).
SMFM Consult: Activity restriction in pregnancy
In repeated measures models, when compared with women who reported no VMS symptoms, those who reported moderate to severe VMS had 0.015 g/cm2 lower femoral neck BMD (95% CI, 0.025 – 0.005) and 0.016 g/cm2 lower lumbar spine BMD (95% CI, 0.032 – 0.004).
The study was limited in that the incidence of fracture in the cohort was low and the general health of WHI participants was better than similarly aged women in the general population. In addition, VMS information was self-reported and assessed at only a baseline visit. BMD data were only available for 4867 participants, meaning that the researchers could not adjust for BMD in the fracture models. An insufficient number of hip fracture events occurred, preventing a more in-depth look at the joint effects of hot flash severity and night sweat severity, along with their corresponding interactions.
The investigators concluded that women who had moderate to severe VMS have increased rates of hip fracture and lower BMD. They believe that further study of the mechanisms underlying the association could aid development of preventive strategies for women who are at risk.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary OB/GYN Special Delivery.
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More
Study links premature menopause to musculoskeletal pain and sarcopenia risks
May 1st 2024A recent study revealed an association between premature menopause and increased risks of musculoskeletal pain and sarcopenia, emphasizing the potential benefits of hormone therapy in mitigating long-term effects.
Read More